JPS501A - - Google Patents
Info
- Publication number
- JPS501A JPS501A JP4884873A JP4884873A JPS501A JP S501 A JPS501 A JP S501A JP 4884873 A JP4884873 A JP 4884873A JP 4884873 A JP4884873 A JP 4884873A JP S501 A JPS501 A JP S501A
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Separation Of Suspended Particles By Flocculating Agents (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4884873A JPS501A (ru) | 1973-04-28 | 1973-04-28 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4884873A JPS501A (ru) | 1973-04-28 | 1973-04-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS501A true JPS501A (ru) | 1975-01-06 |
Family
ID=12814669
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP4884873A Pending JPS501A (ru) | 1973-04-28 | 1973-04-28 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS501A (ru) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018191750A2 (en) | 2017-04-14 | 2018-10-18 | The Broad Institute Inc. | Novel delivery of large payloads |
WO2019222555A1 (en) | 2018-05-16 | 2019-11-21 | Arbor Biotechnologies, Inc. | Novel crispr-associated systems and components |
WO2020102610A1 (en) | 2018-11-14 | 2020-05-22 | The Broad Institute, Inc. | Crispr system based droplet diagnostic systems and methods |
WO2021195079A1 (en) | 2020-03-23 | 2021-09-30 | Regeneron Pharmaceuticals, Inc. | Non-human animals comprising a humanized ttr locus comprising a v30m mutation and methods of use |
EP3889260A1 (en) | 2014-12-12 | 2021-10-06 | The Broad Institute, Inc. | Protected guide rnas (pgrnas) |
EP3929287A2 (en) | 2015-06-18 | 2021-12-29 | The Broad Institute, Inc. | Crispr enzyme mutations reducing off-target effects |
WO2022188039A1 (en) | 2021-03-09 | 2022-09-15 | Huigene Therapeutics Co., Ltd. | Engineered crispr/cas13 system and uses thereof |
-
1973
- 1973-04-28 JP JP4884873A patent/JPS501A/ja active Pending
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3889260A1 (en) | 2014-12-12 | 2021-10-06 | The Broad Institute, Inc. | Protected guide rnas (pgrnas) |
EP3929287A2 (en) | 2015-06-18 | 2021-12-29 | The Broad Institute, Inc. | Crispr enzyme mutations reducing off-target effects |
WO2018191750A2 (en) | 2017-04-14 | 2018-10-18 | The Broad Institute Inc. | Novel delivery of large payloads |
WO2019222555A1 (en) | 2018-05-16 | 2019-11-21 | Arbor Biotechnologies, Inc. | Novel crispr-associated systems and components |
WO2020102610A1 (en) | 2018-11-14 | 2020-05-22 | The Broad Institute, Inc. | Crispr system based droplet diagnostic systems and methods |
WO2021195079A1 (en) | 2020-03-23 | 2021-09-30 | Regeneron Pharmaceuticals, Inc. | Non-human animals comprising a humanized ttr locus comprising a v30m mutation and methods of use |
WO2022188039A1 (en) | 2021-03-09 | 2022-09-15 | Huigene Therapeutics Co., Ltd. | Engineered crispr/cas13 system and uses thereof |